Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. See more conditions.
Research in the laboratory of David G. Monroe, Ph.D., focuses on understanding the molecular mechanisms of how nuclear receptors regulate bone mass. Dr. Monroe's team is particularly interested in the function of estrogen receptors and an orphan nuclear receptor, Rorβ, in regulating the activity of osteoblasts and osteoprogenitor cells within the bone marrow microenvironment in osteoporosis and in aging. Team members use transgenic and mouse models, in vitro models of osteogenesis, and molecular biology in their research.
Understanding the molecular mechanisms that regulate bone mass is an important step in identifying the etiologies underlying bone diseases such as osteoporosis. Since these nuclear receptors have clear effects on bone metabolism, identifying new ways to modulate the activity of these molecules will lead to novel therapies to treat pathological bone loss and bone loss during normal human aging.
Learn about clinical trials that address specific scientific questions about human health and disease.
Explore all research studies at Mayo Clinic.
See the peer-reviewed findings I have published as a result of my research.
Review my research fingerprint, network, grants, projects, publications, Scopus profile, and Altmetrics scores and badges.
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised.
A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.